Stalking influenza diversity with a universal antibody

New England Journal of Medicine

Volumn 365, Issue 16, 2011, Pages 1541-1542

  Russell, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIBODY; HEMAGGLUTININ; INFLUENZA VACCINE; OSELTAMIVIR;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CRYSTAL STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SEASONAL INFLUENZA; SPECIES DIVERSITY; VIRUS STRAIN;

EID: 80054734892     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1109447     Document Type: Article

References (5)

1. Corti D, Voss J, Gamblin SJ, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011;333:850-6.
2. Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009;16:265-73.
3. Ekiert DC, Friesen RHE, Bhabha G, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011;333:843-50.
4. Steel J, Lowen AC. Wang TT, et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 2010;1(1):pii:e00018-10.
5. Bommakanti G, Citron MP, Hepler RW, et al. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci U S A 2010;107:13701-6.